Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
+0.050 (2.78%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 23 | 20 | 47 | - | - | - |
| Market Cap Growth | -54.49% | -56.65% | - | - | - | - |
| Enterprise Value | 23 | 20 | 55 | - | - | - |
| Last Close Price | 1.80 | 1.91 | 5.01 | - | - | - |
| PS Ratio | 171.45 | 156.93 | 840.25 | - | - | - |
| PB Ratio | - | -551.36 | 92.63 | - | - | - |
| P/TBV Ratio | - | - | 73.41 | - | - | - |
| EV/Sales Ratio | 173.50 | 153.39 | 990.71 | - | - | - |
| Debt / Equity Ratio | -89.81 | -89.81 | 0.53 | 0.90 | -0.77 | 1.19 |
| Net Debt / Equity Ratio | -7.22 | -7.22 | -6.70 | -0.95 | -0.55 | -2.73 |
| Net Debt / EBITDA Ratio | -0.01 | -0.01 | 0.22 | 2.73 | -0.58 | 0.57 |
| Net Debt / FCF Ratio | -0.01 | -0.01 | 0.20 | 1.32 | -0.61 | 0.39 |
| Asset Turnover | 0.02 | 0.02 | 0.01 | 0.64 | 0.44 | - |
| Quick Ratio | 0.86 | 0.86 | 1.55 | 5.39 | 1.22 | 3.53 |
| Current Ratio | 1.71 | 1.71 | 2.40 | 5.39 | 1.25 | 3.58 |
| Return on Equity (ROE) | -8159.24% | -8159.24% | -485.36% | 594.25% | - | - |
| Return on Assets (ROA) | -219.58% | -219.58% | -124.04% | -19.46% | -105.01% | - |
| Return on Capital Employed (ROCE) | -709.00% | -709.00% | -357.30% | -20.30% | -540.10% | -110.80% |
| Earnings Yield | -87.20% | -94.03% | -23.68% | - | - | - |
| FCF Yield | -80.82% | -88.30% | -36.47% | - | - | - |
| Buyback Yield / Dilution | -38.47% | -38.47% | -0.11% | -242.70% | -0.01% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.